Classifying ADRs - Does dose matter?

British Journal of Clinical Pharmacology

Volumn 81, Issue 1, 2016, Pages 10-12

  Phillips, Elizabeth J ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALLOPURINOL; DRUG METABOLIZING ENZYME; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PHENYTOIN; QUINOLONE DERIVATIVE; VANCOMYCIN;

ADVERSE DRUG REACTION; ANAPHYLAXIS; CLASSIFICATION; DOSE RESPONSE; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG MECHANISM; EPIDERMOLYSIS; HUMAN; MAST CELL; NOTE; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; DRUG SURVEILLANCE PROGRAM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

EID: 84953346508     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12749     Document Type: Note

References (15)

1. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Textbook of Adverse Drug Reactions, ed David DM. Oxford: Oxford University Press, 1977; 44.
2. McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong X. Identification of amast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 2015; 519: 237-41.
3. Phillips EJ, Sullivan JR, Knowles SR, Shear NH. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS 2002; 16: 2223-5.
4. Lucas A, Lucas M, Strhyn A, Keane NM, McKinnon E, Pavlos R, Moran EM, Meyer-Pannwitt V, Gaudieri S, D'Orsogna L, Kalams S, Ostrov DA, Buus S, Peters B, Mallal S, Phillips E. Abacavir-reactive memory T cells are present in drug naïve individuals. PLoS One 2015; 10: e0117160.
5. Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci 2012; 109: 9959-64.
6. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J. Immune selfreactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012; 486: 554-8.
7. Norcross MA, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies DH, McMurtrey C, Vernon S, Hildebrand WH, Buchli R. Abacavir induces loading of novel self-peptides into HLA-B∗57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS 2012; 26: F21-9.
8. Chung WH, Chang WC, Stocker SL, Juo CG, Graham GG, Lee MH, Williams KM, Tian YC, Juan KC, Jan Wu YJ, Yang CH, Chang CJ, Lin YJ, Day RO, Hung SI. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Ann Rheum Dis 2014 Aug 12 [Epub ahead of print]
9. Chung WH, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, Chen MJ, Lin JY, Hui RC, Ho JC, Wu WM, Chen TJ, Wu T, Wu YR, Hsih MS, Tu PH, Chang CN, Hsu CN, Wu TL, Choon SE, Hsu CK, Chen DY, Liu CS, Lin CY, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang TH, Chuang SS, Tsai SF, Chang CJ, Chang YS, Hung SI. Taiwan severe cutaneous adverse reaction consortium; Japan pharmacogenomics data science consortium. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014; 312: 525-34.
10. Yuan J, Gho S, Hall D, Cammett AM, Jayadev S, Distel M, Storfer S, Huang Z, Mootsikapon P, Roxrungthan K, Podzamuzer D, Haas DW. Toxicogenomics of nevirapineassociated cutaneous and hepatic adverse events among populations of African, Asian, and European descent. AIDS 2011; 25: 1271-80.
11. Nigam SK. What do drug transporters really do? Nat Rev Drug Discov 2015; 14: 29-44.
12. Aronson JK, Ferner RE. The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose related adverse drug reactions Br J Clin Pharmacol 2015; June 28 [epub ahead of print].
13. White K, Chung WH, Hung SI, Mallal S, Phillips E. Evolving models of the immunopathogenesis of T-cell mediated drug allergy: the role of host, pathogens and drug response. J Allerg Clin Immunol 2015; 136: 219-33.
14. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A. PREDICT-1 study team. HLAB∗ 5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358: 568-79.
15. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY. Taiwan SJS consortium. Carbamazepine-induced toxic effects and HLA-B∗1502 screening in Taiwan. N Engl J Med 2011; 364: 1126-33.